O F F I C E R S Dan    Terry,    Briotech    Founder,    CEO    &    CTO:    Dan   Terry   is   an   inventor   and   the   founder   of   Briotech,   Inc.   With 30+    years    of    experience    in    design-for-manufacturability    of    electro-mechanical    and    mechanical    devices, Dan   specializes   in   product   and   component   development,   start-up,   ramp-up,   continuous   improvement   and supply   chain   management.   He   provides   solutions   in   design,   manufacturing   processes,   supplier   selection and   management,   and   component   supply.   Dan’s   specialties   include   'change   agent'   review,   LED   thermal solutions,   thermal   products,   alternative   energy   in   micropower,   hydro-power,   ethanol   distillation,   solar,   clean   coal,   hydrogen, IP    review    and    IP    development.    After    four    years    in    development    at    Danterry,    Inc. ,    Briotech,    Inc.    was    spun    out    as    a manufacturer   of   stable,   ultra-pure   Hypochlorous   Acid   (HOCl)   for   biocide   products,   the   cosmetics   industry,   animal   and   human healthcare,    hospital    disinfection,    pathogen    control,    and    the    agriculture    industries.    Briotech’s    patent-pending    innovations include    new    electrolysis    technology,    development    of    mobile    HOCl    factory    systems     for    disaster    relief    and    pathogen disinfection spray and fogging systems.  linkedin.com/pub/dan-terry Cynthia   Varela,   Briotech   Founder   and   Chief   Administrative   Officer:    Cynthia   Varela   is   the   founder   of Briotech,   Inc.      She   has   worked   alongside   Dan   Terry   for   the   past   26   years,   running   Danterry,   Inc.   and   in   the start-up   of   Briotech.   She   has   over   32   years   of   experience   in   administrative   and   business   management operations.    Her    structured    and    supportive    nature    coupled    with    her    enthusiastic    and    entrepreneurial spirit,   have   proven   key   success   throughout   her   career   and   in   running   her   own   companies.   Cynthia   carries with   her   a   keen   sense   of   company   vision   for   Briotech,   and   specializes   in   strategic   and   thoughtful   carry-through   of   that   vision through customer service. cindi@briotechusa.com Jeff   Williams,   PhD,   BVSc,   MRCVS,   Briotech   Chief   Science   Officer:    Dr.   Williams   had   a   long   career   in academic    microbiology    and    infectious    diseases,    retiring    after    27    years    from    his    position    as    Professor Emeritus   of   Microbiology   and   Molecular   Genetics,   Michigan   State   University   to   found   a   biotechnology start-up,    HaloSource,    Inc.,    in    Seattle,    WA    in    1998.    Retiring    again    in    2014,    he    has    remained    active    as technical    advisor    to    several    companies    in    the    PNW    region,    specializing    in    the    areas    of    antimicrobial chemistry   and   disinfection.   Author   of   over   200   scientific   papers   and   textbook   chapters,   he   served   four   years   as   a   member   of the   Board   of   Counselors   to   the   US-NIH   Institute   of   Allergy   and   Infectious   Diseases,   and   has   been   a   frequent   consultant   to the   World   Health   Organization   of   the   UN   in   Geneva,   Switzerland.   Jeff   was   elected   Fellow   of   the   American   Association   for   the Advancement   of   Science   (AAAS)   in   1996,   and   served   as   retained   consultant   to   first   Merck,   Inc.   (1980-1982),   then   Pharmacia (now   Pfizer,   Inc.)   (1983-1999)   on   therapeutic   drug   discovery   and   development.   He   has   a   long   standing   interest   in   tropical infectious   diseases,   starting   with   his   appointment   as   staff   scientist   for   WHO   in   Argentina   1968-71,   and   for   15   years   directed a   collaborative   NIH-funded   Program   Project   on   Infectious   Diseases   in   Sudan.   He   holds   degrees   in   Veterinary   Science   (BVSc) from   the   University   of   Bristol,   UK   (1964),   and   Pathobiology   (PhD)   from   the   University   of   Pennsylvania   (1968),   where   he   was a Fulbright Scholar (1964-1968).  linkedin.com/pub/jeff-williams Eric   Rasmussen,   MD,   MDM,   FACP,   Chair   of   Advisory   Board:       Dr.   Rasmussen   is   a   global   expert,   consultant and   teacher   in   disaster   medicine   and   response   technologies   in   the   US,   China,   and   Germany.   He   has   25 years   of   experience   as   a   Navy   physician   with   multiple   combat   tours   in   Bosnia,   Iraq   and   Afghanistan,   and more   conventional   medical   experience   as   an   Intensive   Care   Unit   Director   and   Chairman   of   an   academic Department   of   Medicine.   He   spent   nine   years   as   a   Principal   Investigator   with   the   Defense   Advanced Research    Projects    Agency    (DARPA)    and    is    now    the    CEO    of    Infinitum    Humanitarian    Systems,    a    humanitarian    sciences consulting   group   with   projects   in   Mexico,   Tanzania,   Latvia,   Nepal,   the   Philippines,   and   China.   He   also   leads   the   global   disaster response    team    for    the    Roddenberry    Foundation,    supported    by    the    “Star    Trek”    franchise,    and    holds    multiple    academic, advisory, and public service appointments.                                                              linkedin.com/in/ericrasmussenmd A D V I S O R S
Bryan   Hurd,   CISSP,   CISA,   CISM,   CCCI,   CCFT:       Bryan   is   the   Director   of   Advanced   Analytics   Cybercrime   Center   at   Microsoft. Bryan   is   a   global   expert   in   strategic   response   to   terrorism,   cybercrime   and   cyber   security   with   20+   years   of   experience   in military,   government   civilian   and   commercial   corporation   roles.   He   founded   the   first   cyber   counterintelligence   program   for the   US   Navy,   was   in   charge   of   innovation   and   national   data   integration   for   US   watchlisting   and   was   the   first   director   of intelligence for Microsoft’s global cybercrime center.                                                 linkedin.com/in/bryanhurd
Caitlin    Cameron:    Caitlin   is   the   Chairman   and   CEO   of   OtoNexus   Medical   Technologies.   She   is   a   highly-accomplished   senior executive    with    30    years    cross-industry    expertise    in    the    Life    Sciences,    Biotech    Technology,    and    IT    industries.    She    is    a specialist   in   building   successful   start-up   companies   and   taking   them   through   to   successful   exit.   Previously,   she   held   Chair and   CEO   positions   at   several   Life   Sciences   and   IT   companies,   building   successful   businesses   and   organizations,   creating value and maximizing potential in a very short period of time. linkedin.com/in/caitlincameron
CONTACT THE BRIOTECH TEAM
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2018
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2018
Jeremy    Stone:     Jeremy    is    a    physician,    entrepreneur    and    financier,    with    international    interests    in    life    sciences,    aviation, transport,   structured   finance,   healthcare   reform   and   strategy.   Trained   in   the   British   National   Health   Service,   he   has   worked globally   as   investor,   Chair,   CFO,   CEO   and   COO,   yet   inside   remains   a   physician   with   a   passion   for   disruptive   life-enhancing innovation.                             linkedin.com/in/jeremy-stone-md-mba 
FDA FACILITY REG #3012261723 | EPA #93108
CONTACT THE BRIOTECH TEAM
Dan   Terry,   Briotech   Founder,   CEO   &   CTO:    Dan Terry   is   an   inventor   and   the   founder   of   Briotech, Inc.   With   30+   years   of   experience   in   design-for- manufacturability     of     electro-mechanical     and     mechanical devices,      Dan      specializes      in      product      and      component development,    start-up,    ramp-up,    continuous    improvement and    supply    chain    management.    He    provides    solutions    in design,     manufacturing     processes,     supplier     selection     and management,      and      component      supply.      Dan’s      specialties include     'change     agent'     review,     LED     thermal     solutions, thermal   products,   alternative   energy   in   micropower,   hydro- power,     ethanol     distillation,     solar,     clean     coal,     hydrogen,                                                                   IP      review      and      IP      development.      After      four      years      in development   at   Danterry,   Inc. ,   Briotech,   Inc.   was   spun   out   as a     manufacturer     of     stable,     ultra-pure     Hypochlorous     Acid (HOCl)   for   biocide   products,   the   cosmetics   industry,   animal and      human      healthcare,      hospital      disinfection,      pathogen control,    and    the    agriculture        industries.    Briotech’s    patent- pending    innovations    include    new    electrolysis    technology, development    of    mobile    HOCl    factory    systems     for    disaster relief and pathogen disinfection spray and fogging systems.  linkedin.com/pub/dan-terry Cynthia     Varela,     Briotech     Founder     and     Chief Administrative     Officer:      Cynthia     Varela     is     the founder      of      Briotech,      Inc.      She      has      worked alongside   Dan   Terry   for   the   past   26   years,   running   Danterry, Inc.   and   in   the   start-up   of   Briotech.   She   has   over   32   years   of experience     in     administrative     and     business     management operations.    Her    structured    and    supportive    nature    coupled with   her   enthusiastic   and   entrepreneurial   spirit,   have   proven key   success   throughout   her   career   and   in   running   her   own companies.   Cynthia   carries   with   her   a   keen   sense   of   company vision      for      Briotech,      and      specializes      in      strategic      and thoughtful    carry-through    of    that    vision    through    customer service. cindi@briotechusa.com Jeff     Williams,     PhD,     BVSc,     MRCVS,     Briotech Chief    Science    Officer:     Dr.    Williams    had    a    long career    in    academic    microbiology    and    infectious diseases,     retiring     after     27     years     from     his     position     as Professor   Emeritus   of   Microbiology   and   Molecular   Genetics, Michigan   State   University   to   found   a   biotechnology   start-up, HaloSource,    Inc.,    in    Seattle,    WA    in    1998.    Retiring    again    in 2014,   he   has   remained   active   as   technical   advisor   to   several companies    in    the    PNW    region,    specializing    in    the    areas    of antimicrobial   chemistry   and   disinfection.   Author   of   over   200 scientific   papers   and   textbook   chapters,   he   served   four   years as    a    member    of    the    Board    of    Counselors    to    the    US-NIH Institute   of   Allergy   and   Infectious   Diseases,   and   has   been   a frequent   consultant   to   the   World   Health   Organization   of   the UN   in   Geneva,   Switzerland.   Jeff   was   elected   Fellow   of   the American     Association     for     the     Advancement     of     Science (AAAS)   in   1996,   and   served   as   retained   consultant   to   first Merck,    Inc.    (1980-82),    then    Pharmacia    (now    Pfizer,    Inc.) (1983-99)   on   therapeutic   drug   discovery   and   development. He   has   a   long   standing   interest   in   tropical   infectious   diseases, starting   with   his   appointment   as   staff   scientist   for   WHO   in Argentina   1968-71,   and   for   15   years   directed   a   collaborative NIH-funded     Program     Project     on     Infectious     Diseases     in Sudan.   He   holds   degrees   in   Veterinary   Science   (B.V.Sc.)   from the   University   of   Bristol,   UK   (1964),   and   Pathobiology   (Ph.D) from   the   University   of   Pennsylvania   (1968),   where   he   was   a Fulbright Scholar (1964-68).  linkedin.com/pub/jeff-williams Eric     Rasmussen,     MD,     MDM,     FACP,     Briotech Chair   of   the   Advisory   Board:    Dr.   Rasmussen   is   a global   expert,   consultant   and   teacher   in   disaster medicine    and    response    technologies    in    the    US,    China,    and Germany.   He   has   25   years   of   experience   as   a   Navy   physician with   multiple   combat   tours   in   Bosnia,   Iraq   and   Afghanistan, and    more    conventional    medical    experience    as    an    Intensive Care      Unit      Director      and      Chairman      of      an      academic Department   of   Medicine.   He   spent   nine   years   as   a   Principal Investigator   with   the   Defense   Advanced   Research   Projects Agency      (DARPA)      and      is      now      the      CEO      of      Infinitum Humanitarian    Systems,    a    humanitarian    sciences    consulting group   with   projects   in   Mexico,   Tanzania,   Latvia,   Nepal,   the Philippines,    and    China.    He    also    leads    the    global    disaster response   team   for   the   Roddenberry   Foundation,   supported by    the    “Star    Trek”    franchise,    and    holds    multiple    academic, advisory, and public service appointments.                                                              linkedin.com/in/ericrasmussenmd A D V I S O R S
Bryan   Hurd,   CISSP,   CISA,   CISM,   CCCI,   CCFT:    Bryan   is   the   Director   of Advanced   Analytics   Cybercrime   Center   at   Microsoft.   Bryan   is   a   global expert   in   strategic   response   to   terrorism,   cybercrime   and   cyber   security with    20+    years    of    experience    in    military,    government    civilian    and commercial       corporation       roles.       He       founded       the       first       cyber counterintelligence     program     for     the     US     Navy,     was     in     charge     of innovation   and   national   data   integration   for   US   watchlisting   and   was   the first director of intelligence for Microsoft’s global cybercrime center.                                                linkedin.com/in/bryanhurd
Caitlin     Cameron:      Caitlin     is     the     Chairman     and     CEO     of     OtoNexus Medical    Technologies.    She    is    a    highly-accomplished    senior    executive with    30    years    cross-industry    expertise    in    the    Life    Sciences,    Biotech Technology,   and   IT   industries.   She   is   a   specialist   in   building   successful start-up     companies     and     taking     them     through     to     successful     exit. Previously,   she   held   Chair   and   CEO   positions   at   several   Life   Sciences and    IT    companies,    building    successful    businesses    and    organizations, creating value and maximizing potential in a very short period of time. linkedin.com/in/caitlincameron
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2018
BRIOTECH, ITS LOGOS, LANGUAGE & IMAGES ARE TRADEMARKS & COPYRIGHT PROPERTY OF BRIOTECH, INC. & ITS AFFILIATES. © 2013-2018
Jeremy   Stone:    Jeremy   is   a   physician,   entrepreneur   and   financier,   with international    interests    in    life    sciences,    aviation,    transport,    structured finance,   healthcare   reform   and   strategy.   Trained   in   the   British   National Health   Service,   he   has   worked   globally   as   investor,   Chair,   CFO,   CEO   and COO,   yet   inside   remains   a   physician   with   a   passion   for   disruptive   life- enhancing innovation.                             linkedin.com/in/jeremy-stone-md-mba 
FDA FACILITY REG #3012261723 | EPA #93108
O F F I C E R S
T H E   B R I O   T E A M